STOCK TITAN

[Form 4] INTEGRAL AD SCIENCE HOLDING CORP. Insider Trading Activity

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Integral Ad Science Holding Corp. (IAS) chief executive and director reported the vesting and partial sale of equity awards on 10/03/2025. 18,133 shares were acquired upon vesting of market stock units and 17,267 shares were sold at a weighted average price of $10.19 per share to cover tax withholding. After these transactions the reporting person beneficially owned 432,560 shares. The filing explains the market stock units were granted on 04/03/2023, can pay out up to 225% of target, and vest over a multi‑year schedule with an initial 25% vesting date on 04/03/2024 and quarterly installments thereafter.

Integral Ad Science Holding Corp. (IAS) il presidente esecutivo e direttore ha riportato la maturazione e la vendita parziale di premi azionari il 10/03/2025. 18,133 azioni sono state acquisite al vesting delle unità azionarie di mercato e 17,267 azioni sono state vendute a un prezzo medio ponderato di $10.19 per azione per coprire le ritenute fiscali. Dopo queste operazioni la persona che presenta la dichiarazione possedeva beneficiariamente 432,560 azioni. La dichiarazione spiega che le unità azionarie di mercato sono state concesse il 04/03/2023, possono pagare fino a 225% dell'obiettivo, e vestire secondo un piano pluriennale con una prima data di vesting del 25% il 04/03/2024 e rate trimestrali successivi.

Integral Ad Science Holding Corp. (IAS) el director ejecutivo y director reportó el vesting y la venta parcial de premios de acciones el 10/03/2025. Se adquirieron 18,133 acciones al vesting de unidades de acción de mercado y se vendieron 17,267 a un precio medio ponderado de $10.19 por acción para cubrir la retención de impuestos. Después de estas transacciones, la persona que presenta el informe poseía beneficiosamente 432,560 acciones. La declaración explica que las unidades de acciones de mercado se otorgaron el 04/03/2023, pueden pagar hasta 225% del objetivo, y vestirse según un calendario plurianual con una fecha inicial de vesting del 25% el 04/03/2024 y pagos trimestrales en adelante.

Integral Ad Science Holding Corp. (IAS)의 최고경영자 겸 이사가 2025.10.03에 주식권의 시가 vesting 및 일부 매각을 보고했습니다. 18,133주가 시장주식단위의 vesting으로 취득되었고 17,267주는 주당 $10.19의 가중평균가로 매각되어 세금 원천징수를 위한 것입니다. 이 거래 이후 보고인은 실질적으로 432,560주를 보유했습니다. 제출서는 시장주식단위가 2023.04.03에 부여되었고 225%의 목표까지 지급될 수 있으며 다년 일정에 따라 vesting되며 초기 vesting 날짜가 2024.04.03이고 이후 분기별 분할로 이행된다고 설명합니다.

Integral Ad Science Holding Corp. (IAS) le directeur général et administrateur a signalé l'acquisition et la cession partielle des attributions d'actions le 10/03/2025. 18,133 actions ont été acquises lors de la maturation des unités d'actions de marché et 17,267 actions ont été vendues à un prix moyen pondéré de $10.19 par action pour couvrir les retenues d'impôt. Après ces transactions, la personne déclarant détenait bénéfi­ci­ement 432,560 actions. Le dossier explique que les unités d'actions de marché ont été attribuées le 04/03/2023, peuvent verser jusqu'à 225% de l'objectif, et vestir selon un calendrier pluriannuel avec une première date de vesting le 04/03/2024 et des versements trimestriels par la suite.

Integral Ad Science Holding Corp. (IAS) Geschäftsführer und Direktor meldeten die Freigabe und den teilweisen Verkauf von Aktienzuteilungen am 10/03/2025. 18,133 Aktien wurden bei der Vesting-Bedingung von Market Stock Units erworben und 17,267 Aktien wurden zu einem gewichteten Durchschnittspreis von $10.19 pro Aktie verkauft, um die Steuerrückforderungen abzudecken. Nach diesen Transaktionen hielt die meldende Person vorteilhafterweise 432,560 Aktien. Die Einreichung erklärt, dass die Market Stock Units am 04/03/2023 gewährt wurden, bis zu 225% des Ziels auszahlen können und gemäß einem mehrjährigen Zeitplan mit einer ersten Vesting-Rate von 25% am 04/03/2024 vesten und danach vierteljährliche Raten erfolgen.

Integral Ad Science Holding Corp. (IAS) الرئيس التنفيذي والمدير أبلغ عن استحقاق وبيع جزئي لجوائز الأسهم في 10/03/2025. تم الاستحواذ على 18,133 سهماً عند استحقاق وحدات الأسهم السوقية و17,267 سهماً بيع بسعر متوسط مرجح قدره $10.19 للسهم لتغطية احتجاز الضرائب. بعد هذه المعاملات امتلك الشخص المبلغ عنه بشكل مستفيد 432,560 سهماً. يشرح الملف أن وحدات الأسهم السوقية منحت في 04/03/2023، ويمكن أن تدفع حتى 225% من الهدف، وتستحق وفق جدول متعدد السنوات مع تاريخ استحقاق ابتدائي 25% في 04/03/2024 وتوزيعات ربع سنوية من بعدها.

Integral Ad Science Holding Corp. (IAS) 首席执行官兼董事报告了在 2025/10/03 的归属与部分股票奖励出售。18,133 股在市场股票单位归属时取得,17,267 股以加权平均价格 $10.19 /股出售,以覆盖税款扣缴。交易完成后,报告人实际持有 432,560 股。 文件说明市场股票单位是在 2023/04/03 授予的,最高可支付目标的 225%,并按多年的计划分期归属,初始归属日期为 2024/04/03,此后按季度分期发放。

Positive
  • Vesting occurred under performance-linked market stock units, aligning pay with share performance
  • Majority of shares retained after sell-to-cover: reporting person still owns 432,560 shares
Negative
  • Sell-to-cover executed resulting in a disposal of 17,267 shares at a weighted average of $10.19
  • Potential dilution remains from MSU program with up to 225% of target payout

Insights

TL;DR: CEO received vested market stock units and completed a mandatory sell-to-cover for taxes on the same date.

The reporting person realized 18,133 shares from vested market stock units that were granted on 04/03/2023. The filing states a mandatory disposition of 17,267 shares occurred to satisfy tax withholding at a weighted average price of $10.19 per share.

This structure—market stock units with up to 225% payout and a 60% minimum threshold—ties vesting to post‑grant stock performance and includes scheduled quarterly vesting through the multi‑year period beginning 04/03/2024

Watch near‑term dilution and insider selling patterns over the next 12 months as remaining MSUs vest and any further sell‑to‑cover events occur.

TL;DR: Transaction is routine compensation settlement and tax withholding, but signals ongoing equity dilution from performance units.

The filing clarifies the sale was a mandatory tax withholding action tied to settlement rather than a discretionary open‑market disposition. The reporting person still holds 432,560 shares after the transactions.

Key governance items to monitor include the remaining contingent maximum payout under the award (225% of target) and the quarterly vesting schedule that may cause further share issuances through the vesting horizon.

Integral Ad Science Holding Corp. (IAS) il presidente esecutivo e direttore ha riportato la maturazione e la vendita parziale di premi azionari il 10/03/2025. 18,133 azioni sono state acquisite al vesting delle unità azionarie di mercato e 17,267 azioni sono state vendute a un prezzo medio ponderato di $10.19 per azione per coprire le ritenute fiscali. Dopo queste operazioni la persona che presenta la dichiarazione possedeva beneficiariamente 432,560 azioni. La dichiarazione spiega che le unità azionarie di mercato sono state concesse il 04/03/2023, possono pagare fino a 225% dell'obiettivo, e vestire secondo un piano pluriennale con una prima data di vesting del 25% il 04/03/2024 e rate trimestrali successivi.

Integral Ad Science Holding Corp. (IAS) el director ejecutivo y director reportó el vesting y la venta parcial de premios de acciones el 10/03/2025. Se adquirieron 18,133 acciones al vesting de unidades de acción de mercado y se vendieron 17,267 a un precio medio ponderado de $10.19 por acción para cubrir la retención de impuestos. Después de estas transacciones, la persona que presenta el informe poseía beneficiosamente 432,560 acciones. La declaración explica que las unidades de acciones de mercado se otorgaron el 04/03/2023, pueden pagar hasta 225% del objetivo, y vestirse según un calendario plurianual con una fecha inicial de vesting del 25% el 04/03/2024 y pagos trimestrales en adelante.

Integral Ad Science Holding Corp. (IAS)의 최고경영자 겸 이사가 2025.10.03에 주식권의 시가 vesting 및 일부 매각을 보고했습니다. 18,133주가 시장주식단위의 vesting으로 취득되었고 17,267주는 주당 $10.19의 가중평균가로 매각되어 세금 원천징수를 위한 것입니다. 이 거래 이후 보고인은 실질적으로 432,560주를 보유했습니다. 제출서는 시장주식단위가 2023.04.03에 부여되었고 225%의 목표까지 지급될 수 있으며 다년 일정에 따라 vesting되며 초기 vesting 날짜가 2024.04.03이고 이후 분기별 분할로 이행된다고 설명합니다.

Integral Ad Science Holding Corp. (IAS) le directeur général et administrateur a signalé l'acquisition et la cession partielle des attributions d'actions le 10/03/2025. 18,133 actions ont été acquises lors de la maturation des unités d'actions de marché et 17,267 actions ont été vendues à un prix moyen pondéré de $10.19 par action pour couvrir les retenues d'impôt. Après ces transactions, la personne déclarant détenait bénéfi­ci­ement 432,560 actions. Le dossier explique que les unités d'actions de marché ont été attribuées le 04/03/2023, peuvent verser jusqu'à 225% de l'objectif, et vestir selon un calendrier pluriannuel avec une première date de vesting le 04/03/2024 et des versements trimestriels par la suite.

Integral Ad Science Holding Corp. (IAS) Geschäftsführer und Direktor meldeten die Freigabe und den teilweisen Verkauf von Aktienzuteilungen am 10/03/2025. 18,133 Aktien wurden bei der Vesting-Bedingung von Market Stock Units erworben und 17,267 Aktien wurden zu einem gewichteten Durchschnittspreis von $10.19 pro Aktie verkauft, um die Steuerrückforderungen abzudecken. Nach diesen Transaktionen hielt die meldende Person vorteilhafterweise 432,560 Aktien. Die Einreichung erklärt, dass die Market Stock Units am 04/03/2023 gewährt wurden, bis zu 225% des Ziels auszahlen können und gemäß einem mehrjährigen Zeitplan mit einer ersten Vesting-Rate von 25% am 04/03/2024 vesten und danach vierteljährliche Raten erfolgen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Utzschneider Lisa

(Last) (First) (Middle)
C/O INTEGRAL AD SCIENCE HOLDING CORP.
12 E 49TH STREET, 20TH FLOOR

(Street)
NEW YORK NY 10017

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
INTEGRAL AD SCIENCE HOLDING CORP. [ IAS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
10/03/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, $0.001 par value 10/03/2025 M 18,133(1) A $0 432,560 D
Common Stock, $0.001 par value 10/03/2025 S(2) 17,267 D $10.19(3) 415,293 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Market Stock Units (4) 10/03/2025 M 18,133 (5) (5) Common Stock, $0.001 par value 18,133 $0 354,765 D
Explanation of Responses:
1. Represents shares of common stock earned upon the vesting of market stock units granted on April 3, 2023.
2. Mandatory sale to cover tax liability associated with the settlement of market stock units.
3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.18 to $10.20 per share. The reporting person undertakes to provide to Integral Ad Science Holding Corp., any security holder of Integral Ad Science Holding Corp. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
4. The number of market stock units reported represents the maximum possible number of shares that are eligible for vesting, which is 225% of the number of shares that would be earned at target. The minimum payout factor that must be achieved to earn any payout is 60%. The actual number of shares that will vest on each vesting date will be determined by comparing the price of common stock on the applicable vesting date to the price of common stock on April 3, 2023 (i.e number of vested shares is equal to (i) the number of shares at target payout multiplied by (ii)(a) the average price of common stock for the 10 trading days immediately proceeding the applicable vesting date divided by (b) the closing stock price on April 3, 2023).
5. The market stock units vest 25% on April 3, 2024 and in equal installments every three months thereafter over a three year period, subject to the terms and conditions of the applicable award agreement.
Remarks:
/s/ Yossi Almani, by Power of Attorney 10/07/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What happened in the IAS Form 4 filed for IAS on 10/03/2025?

The CEO had 18,133 shares vest from market stock units and a mandatory sale of 17,267 shares occurred to cover taxes at a weighted average price of $10.19 per share.

How many IAS shares does the reporting person own after the transaction?

The reporting person beneficially owned 432,560 shares following the reported transactions.

What are the key terms of the market stock units (MSUs)?

MSUs were granted on 04/03/2023, vest quarterly after an initial 25% vesting on 04/03/2024, and can pay up to 225% of target with a 60% minimum threshold to earn any payout.

Why were shares sold in the transaction?

The filing states the sale was a mandatory sale to cover tax liability associated with the settlement of market stock units.

At what prices were the shares sold?

Shares were sold in multiple transactions at prices ranging from $10.18 to $10.20, with a reported weighted average of $10.19.
Integral Ad Science Holding Corp.

NASDAQ:IAS

IAS Rankings

IAS Latest News

IAS Latest SEC Filings

IAS Stock Data

1.70B
100.31M
0.94%
97.72%
3.52%
Advertising Agencies
Services-computer Programming, Data Processing, Etc.
Link
United States
NEW YORK